Samuel Waxman Cancer Research Foundation
Samuel Waxman Cancer Research Foundation shows consistent asset growth and no reported officer compensation.
EIN: 133020943 · New York, NY · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $9.6M |
| Total Expenses | $4.0M |
| Program Spending | 80% |
| Net Assets | $5.9M |
| Transparency Score | 85/100 |
Is Samuel Waxman Cancer Research Foundation Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
Samuel Waxman Cancer Research Foundation directs 80% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Samuel Waxman Cancer Research Foundation
Samuel Waxman Cancer Research Foundation (EIN: 133020943) is a nonprofit organization based in New York, NY. The organization reported total revenue of $9.6M and total assets of $5.4M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Samuel Waxman Cancer Research Foundation's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Samuel Waxman Cancer Research Foundation is a mid-size nonprofit that has been operating for 43 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 0.0%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $4.0M |
| Total Expenses | $4.0M |
| Surplus / Deficit | +$4K |
| Total Assets | $6.2M |
| Total Liabilities | $310K |
| Net Assets | $5.9M |
| Operating Margin | 0.1% |
| Debt-to-Asset Ratio | 5.0% |
| Months of Reserves | 18.5 months |
Financial Health Grade: A
In 2023, Samuel Waxman Cancer Research Foundation reported a surplus of $4K with revenue exceeding expenses, holds 18.5 months of operating reserves (strong position), has a debt-to-asset ratio of 5.0% (very low leverage).
Financial Trends
Over 13 years of filings (2011–2023), Samuel Waxman Cancer Research Foundation's revenue has grown at a compound annual growth rate (CAGR) of 0.0%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | -14.8% | +38.2% | +0.8% |
| 2022 | +87.4% | -19.4% | +26.7% |
| 2021 | -51.8% | +6.1% | -5.9% |
| 2020 | +27.7% | +15.3% | +54.4% |
| 2019 | +11.8% | +5.6% | +52.2% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 1983 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Samuel Waxman Cancer Research Foundation with a Mission Score of 85 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 10%
- programs: 80%
- fundraising: 10%
According to IRS 990 filings, Samuel Waxman Cancer Research Foundation allocates its expenses as follows: admin: 10%, programs: 80%, fundraising: 10%. With 80% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $4K, with revenue exceeding expenses.
- Debt-to-asset ratio: 5.0%.
Executive Compensation Analysis
Executive compensation is reported as 0% across all available filings, indicating that no officers received reportable compensation directly from the organization, which is a positive sign for directing funds to the mission.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of Samuel Waxman Cancer Research Foundation's IRS 990 filings:
- Fluctuating revenue year-over-year, making future income less predictable (e.g., $4.7M in 2022 vs. $4.0M in 2023).
Strengths
The following positive indicators were identified for Samuel Waxman Cancer Research Foundation:
- Consistent asset growth over time, indicating financial health (from $1.4M in 2016 to $6.1M in 2023).
- No reported officer compensation, suggesting high efficiency in directing funds to mission.
- Generally operates with a revenue surplus, demonstrating sound financial management (e.g., $1.8M surplus in 2022).
- Liabilities are consistently well-managed and significantly lower than assets.
Frequently Asked Questions about Samuel Waxman Cancer Research Foundation
Is Samuel Waxman Cancer Research Foundation a legitimate charity?
Samuel Waxman Cancer Research Foundation (EIN: 133020943) is a registered tax-exempt nonprofit based in New York. Our AI analysis gives it a Mission Score of 85/100. It has 13 years of IRS 990 filings on record. Total revenue: $9.6M. 1 red flag identified. 4 strengths noted. Financial health grade: A.
How does Samuel Waxman Cancer Research Foundation spend its money?
Samuel Waxman Cancer Research Foundation directs 80% of its spending to programs and services. Fundraising costs 10%. This exceeds the 65% industry benchmark.
Are donations to Samuel Waxman Cancer Research Foundation tax-deductible?
Samuel Waxman Cancer Research Foundation is registered as a tax-exempt nonprofit (EIN: 133020943). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
What percentage of Samuel Waxman Cancer Research Foundation's spending goes to programs?
Samuel Waxman Cancer Research Foundation directs 80% to programs, 10% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
Where is Samuel Waxman Cancer Research Foundation located?
Samuel Waxman Cancer Research Foundation is headquartered in New York, New York and files with the IRS under EIN 133020943.
How many years of IRS 990 filings does Samuel Waxman Cancer Research Foundation have?
Samuel Waxman Cancer Research Foundation has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $9.6M in total revenue.
Is the Samuel Waxman Cancer Research Foundation financially stable?
Yes, the foundation appears financially stable, consistently maintaining assets significantly higher than liabilities and often operating with a revenue surplus, as seen in 2022 where revenue was $4,706,095 against expenses of $2,897,746.
How has the organization's revenue trended over time?
Revenue has fluctuated, with a notable dip to $2,510,809 in 2021, but generally shows growth, reaching $4,706,095 in 2022 and $4,008,774 in 2023, compared to $2,307,703 in 2015.
What is the organization's approach to executive compensation?
The organization reports 0% officer compensation across all available filings, suggesting that no officers received reportable compensation directly from the foundation.
Are the organization's assets growing?
Yes, the organization's assets have shown significant growth, increasing from $1,475,608 in 2016 to $6,175,563 in 2023.
Filing History
IRS 990 filing history for Samuel Waxman Cancer Research Foundation showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), Samuel Waxman Cancer Research Foundation's revenue has grown by 0%, moving from $4.0M to $4.0M. Total assets decreased by 13.8% over the same period, from $7.2M to $6.2M. Total functional expenses fell by 20.3%, from $5.0M to $4.0M. In its most recent filing year (2023), Samuel Waxman Cancer Research Foundation reported a surplus of $4K, with revenue exceeding expenses. The organization holds $310K in liabilities against $6.2M in assets (debt-to-asset ratio: 5.0%), resulting in net assets of $5.9M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $4.0M | $4.0M | $6.2M | $310K | — | — |
| 2022 | $4.7M | $2.9M | $6.1M | $301K | — | View 990 |
| 2021 | $2.5M | $3.6M | $4.8M | $916K | — | — |
| 2020 | $5.2M | $3.4M | $5.1M | $238K | — | View 990 |
| 2019 | $4.1M | $2.9M | $3.3M | $246K | — | View 990 |
| 2018 | $3.6M | $2.8M | $2.2M | $247K | — | View 990 |
| 2017 | $2.7M | $2.3M | $1.7M | $659K | — | View 990 |
| 2016 | $2.5M | $2.5M | $1.5M | $721K | — | View 990 |
| 2015 | $2.3M | $2.9M | $1.7M | $964K | — | View 990 |
| 2014 | $2.3M | $3.9M | $2.6M | $1.3M | — | View 990 |
| 2013 | $4.1M | $4.6M | $4.0M | $1.0M | — | View 990 |
| 2012 | $2.7M | $6.3M | $3.8M | $589K | — | View 990 |
| 2011 | $4.0M | $5.0M | $7.2M | $485K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $4.0M, expenses of $4.0M, and assets of $6.2M (revenue -14.8% year-over-year).
- 2022: Revenue of $4.7M, expenses of $2.9M, and assets of $6.1M (revenue +87.4% year-over-year).
- 2021: Revenue of $2.5M, expenses of $3.6M, and assets of $4.8M (revenue -51.8% year-over-year).
- 2020: Revenue of $5.2M, expenses of $3.4M, and assets of $5.1M (revenue +27.7% year-over-year).
- 2019: Revenue of $4.1M, expenses of $2.9M, and assets of $3.3M (revenue +11.8% year-over-year).
- 2018: Revenue of $3.6M, expenses of $2.8M, and assets of $2.2M (revenue +34.6% year-over-year).
- 2017: Revenue of $2.7M, expenses of $2.3M, and assets of $1.7M (revenue +7.0% year-over-year).
- 2016: Revenue of $2.5M, expenses of $2.5M, and assets of $1.5M (revenue +9.7% year-over-year).
- 2015: Revenue of $2.3M, expenses of $2.9M, and assets of $1.7M (revenue -0.4% year-over-year).
- 2014: Revenue of $2.3M, expenses of $3.9M, and assets of $2.6M (revenue -43.4% year-over-year).
- 2013: Revenue of $4.1M, expenses of $4.6M, and assets of $4.0M (revenue +50.6% year-over-year).
- 2012: Revenue of $2.7M, expenses of $6.3M, and assets of $3.8M (revenue -32.1% year-over-year).
- 2011: Revenue of $4.0M, expenses of $5.0M, and assets of $7.2M.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Samuel Waxman Cancer Research Foundation:
Data Sources and Methodology
This transparency report for Samuel Waxman Cancer Research Foundation is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.